| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |